An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Clinical trial NCT03510884 · COMPLETED
Trial details
- NCT number
- NCT03510884
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2021-01-14
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.